1. Home
  2. COSM vs MURA Comparison

COSM vs MURA Comparison

Compare COSM & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COSM
  • MURA
  • Stock Information
  • Founded
  • COSM 2009
  • MURA 2013
  • Country
  • COSM United States
  • MURA Ireland
  • Employees
  • COSM N/A
  • MURA N/A
  • Industry
  • COSM Other Pharmaceuticals
  • MURA
  • Sector
  • COSM Health Care
  • MURA
  • Exchange
  • COSM Nasdaq
  • MURA Nasdaq
  • Market Cap
  • COSM 32.3M
  • MURA 36.0M
  • IPO Year
  • COSM 2013
  • MURA N/A
  • Fundamental
  • Price
  • COSM $0.81
  • MURA $2.09
  • Analyst Decision
  • COSM
  • MURA Buy
  • Analyst Count
  • COSM 0
  • MURA 2
  • Target Price
  • COSM N/A
  • MURA $6.00
  • AVG Volume (30 Days)
  • COSM 972.4K
  • MURA 106.1K
  • Earning Date
  • COSM 11-14-2025
  • MURA 11-04-2025
  • Dividend Yield
  • COSM N/A
  • MURA N/A
  • EPS Growth
  • COSM N/A
  • MURA N/A
  • EPS
  • COSM N/A
  • MURA N/A
  • Revenue
  • COSM $55,093,442.00
  • MURA N/A
  • Revenue This Year
  • COSM $28.14
  • MURA N/A
  • Revenue Next Year
  • COSM N/A
  • MURA N/A
  • P/E Ratio
  • COSM N/A
  • MURA N/A
  • Revenue Growth
  • COSM N/A
  • MURA N/A
  • 52 Week Low
  • COSM $0.28
  • MURA $0.95
  • 52 Week High
  • COSM $1.32
  • MURA $4.74
  • Technical
  • Relative Strength Index (RSI)
  • COSM 35.10
  • MURA 52.55
  • Support Level
  • COSM $0.98
  • MURA $2.06
  • Resistance Level
  • COSM $1.04
  • MURA $2.10
  • Average True Range (ATR)
  • COSM 0.11
  • MURA 0.01
  • MACD
  • COSM -0.03
  • MURA 0.00
  • Stochastic Oscillator
  • COSM 8.26
  • MURA 66.67

About COSM Cosmos Health Inc.

Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

Share on Social Networks: